R1 RCM Inc (RCM) Receives Average Recommendation of “Buy” from Analysts

Shares of R1 RCM Inc (NASDAQ:RCM) have been given an average recommendation of “Buy” by the eight research firms that are covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $11.75.

RCM has been the topic of a number of research reports. Chardan Capital initiated coverage on shares of R1 RCM in a research note on Tuesday, September 4th. They issued a “buy” rating and a $17.00 target price on the stock. TheStreet raised shares of R1 RCM from a “d+” rating to a “c” rating in a research note on Tuesday, September 4th. Zacks Investment Research raised shares of R1 RCM from a “strong sell” rating to a “hold” rating in a research note on Wednesday, July 18th. BidaskClub downgraded shares of R1 RCM from a “buy” rating to a “hold” rating in a research note on Saturday, October 13th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $10.00 target price on shares of R1 RCM in a research note on Friday, July 27th.

NASDAQ:RCM opened at $8.49 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 15.78. The company has a market cap of $1.12 billion, a price-to-earnings ratio of -19.30 and a beta of -0.76. R1 RCM has a fifty-two week low of $3.56 and a fifty-two week high of $11.00.

R1 RCM (NASDAQ:RCM) last issued its earnings results on Thursday, August 9th. The financial services provider reported ($0.07) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.02). R1 RCM had a negative net margin of 11.31% and a negative return on equity of 52.71%. The business had revenue of $207.90 million during the quarter, compared to analysts’ expectations of $200.59 million. R1 RCM’s revenue was up 109.2% on a year-over-year basis. On average, equities analysts predict that R1 RCM will post -0.17 earnings per share for the current fiscal year.

In other news, Director Albert Rene Zimmerli purchased 10,000 shares of the stock in a transaction that occurred on Thursday, September 6th. The stock was acquired at an average cost of $9.73 per share, with a total value of $97,300.00. Following the acquisition, the director now owns 10,000 shares in the company, valued at $97,300. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 59.40% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC acquired a new position in R1 RCM during the 1st quarter worth $100,000. GSA Capital Partners LLP acquired a new position in R1 RCM during the 2nd quarter worth $122,000. Teacher Retirement System of Texas acquired a new position in R1 RCM during the 2nd quarter worth $147,000. Allianz Asset Management GmbH acquired a new position in R1 RCM during the 1st quarter worth $148,000. Finally, Jane Street Group LLC acquired a new position in R1 RCM during the 2nd quarter worth $190,000. 49.75% of the stock is owned by institutional investors and hedge funds.

R1 RCM Company Profile

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Recommended Story: Understanding Compound Annual Growth Rate (CAGR)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply